Get the latest news, views and opinions from Fidelity’s savings and investment experts on using brokerage to invest in individual shares.
Cerebras Systems, the pioneer in accelerating artificial intelligence (AI) compute, released yet another industry-first capability today. Customers ca
GSK plc (GSK) Stock Decreases -1.75% This Week; Should You Buy?
Barclays analyst Iain Simpson maintains his Neutral opinion on the stock. | August 30, 2022
GlaxoSmithKline Pharmaceuticals Ltd. GSK House, Dr. Annie Besant Road, Worli, Mumbai -... | August 30, 2022
Quadintel recently added a research report on the Global Albuterol Sulfate Metered Dose Inhalers Mar
Global Malted Milk Market Status, Trends and COVID-19 Impact Report 2021, Covid 19 Outbreak Impact r
Global Graft Versus Host Disease Treatment Market Global Graft Versus Host Disease Treatment Market Dublin, Aug. 30, 2022 (GLOBE NEWSWIRE) -- The “Global Graft Versus Host Disease Treatment Market (2022-2027) by Disease Type, Product, Geography, Competitive Analysis and the Impact of Covid-19 with A…
Quadintel recently added a research report on the Global Belimumab Market. The report includes an ex
The week in pharma: action, reaction and insight – week to August 26
The Indian unit of British drugmaker GSK further alleged that Nicholas Healthcare and Akums are also using identical packaging to take advantage of the popularity of its brand, people aware of the development said.
In COVID-19 news, both Pfizer and Moderna have submitted applications for an updated booster vaccine, and the FDA grants EUA for Novavax vaccine for adolescents. The agency also approved rapid-acting Auvelity for major depression, expanded Imbruvica for young children with GVHD, expanded use of Omni…
In a pre-planned interim data analysis, Pfizer said its shot was strongly protective against severe disease and plans to submit the results to regulators this fall.
Why is the AstraZeneca share price outperforming its rivals GlaxoSmithKline and PureTech Health? Read our biopharma news update.
Citigroup put pharmaceuticals company GlaxoSmithKline on “positive catalyst watch” on Friday as it pointed to legal developments related to the company’s now-discontinued Zantac heartburn drug.
Shore Capital reiterated a “not rated” rating on shares of GSK in a research note on Thursday.
Analysis: Novartis CEO may struggle to rally investors to Sandoz spin-off – PharmaLive PharmaLive
The GSK3 inhibitor CHIR99021 is required to maintain the alveolar lineage in alveolar progenitors grown in airway media or AT2 cells become plastic, with the observed effects acting outside of its role as a GSK3B inhibitor.
Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.
24 August 2022 The General Manager Pakistan Stock Exchange Limited, Stock Exchange Building, ... | August 24, 2022